12
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Plasminogen-binding activity of enolase in the opportunistic pathogen Pneumocystis carinii

&
Pages 495-507 | Published online: 09 Jul 2009

References

  • Al-Giery AG, Brewer JM. Characterization of the interaction of yeast enolase with polynucleotides. Biochim Biophys Acta 1992; 1159: 134–140.
  • Just I, Fritz G, Aktories K, etal. Clostridium difficile toxin B acts on the GTP-binding protein Rho. J Biol Chem 1994; 269:10706–10712.
  • Knoop F, Martig R, Owens M. Degradation of 2-phosphogly-cerate by cytotoxin B of Clostridium difficile. FEBS Lett 1990; 267: 9–12.
  • Wistow G, Piatigorsky J. Recruitment of enzymes as lens structural proteins. Science 1987; 236: 1554–1556.
  • Iida H, Yahara L Yeast heat-shock protein of Mr 48,000 is an isoprotein of enolase. Nature 1985; 315: 688–690.
  • Bissaret FJ, Keith G, Rihn B, etal. H. Clostridium difficile toxin B: characterization and sequence of three peptides. J Chroma-togr 1989; 490: 91–100.
  • Angiolella L, Facchin M, Stringaro A, et al. Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics. J Infect Dis 1996; 173: 684–690.
  • Eroles P, Sentandreu M, Elorza MV, Sentandreu R. The highly immunogenic enolase and hsp70p are adventitious Candida albicans cell wall proteins. Microbiology 1997; 143: 313–320.
  • Franklyn KM, Warmington JR, Ott AK, Ashman RB. An immunodominant antigen of Candida albicans shows homology to the enzyme enolase. Immunol Cell Biol 1990; 68: 173–178.
  • Martinez JP, Gil ML, Lopez-Ribot JL, Chaffin WL. Serological response to cell wall mannoproteins and proteins of Candida albicans. Clin Microbiol Rev 1998; 11: 121–141.
  • Mitsutake K, Miyazaki T, Tashiro T, et al. Enolase antigen, mannan antigen, C- and Tec antigen, and b-glucan in patients with candidemia. J Clin Microbiol 1996; 34: 1918–1921.
  • Peterson P, Perheentupa J, Krohn KJ. Detection of candidal antigens in autoimmune polyglandular syndrome type 1. Clin Diagn Lab Immunol 1996; 3: 290–294.
  • Sundstrom P, Jensen J, Balish E. Humoral and cellular immune reponses to enolase after alimentary tract colonization or intravenous immunization with Candida albicans. J Infect Dis 1994; 170: 390–395.
  • Van Deventer MM, Van Vliet, HJA, Hop WCJ, Goessens WHF. Diagnostic value of anti-Candida enolase antibodies. J Clin Microbiol 1994; 32: 17–23.
  • Walsh TJ, Chanock SJ. Laboratory diagnosis of invasive candidiasis: a rationale for complementary use of culture- and nonculture-based detection systems. Int J Infect Dis 1997; 1: S11–S19.
  • Kortekangas-Savolainen O, Kalimo K, Lammintausta K, Savo-lainen J. IgE-binding components of baker's yeast (Sacchar-omyces cerevisiae) recognized by immunoblotting analysis. Simultaneous IgE binding to mannan and 46-48 kD allergans of Saccharomyces cerevisiae and Candida albicans. Clin Exp Allergy 1993; 23: 179–184.
  • Ishiguro A, Homma M, Toni S, Tanaka K. Identification of Candida albicans antigens reactive with immunoglobulin E antibody of human sera. Infect Immun 1992; 60: 1550–1557.
  • Ito K, Ishiguro A, Kanbe T, Tanaka K, Toni S. Detection of IgE antibody against Candida albicans enolase and its crossreactivity to Saccharomyces cerevisiae enolase. Gun Exp Allergy 1995; 25: 522–528.
  • Walzer PD, Pen i DP, Krogstad DJ, Rawson PG, Schultz MG. Pneumocystis carinii pneumonia in the United States. Annal Intern Med 1974; 80: 83–93.
  • Schmatz DM, Abruzzo G, Powles MA, et al. Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumo-cystis carinii and Candida species. J Antibiot 1992; 45: 1886–1891.
  • Nollstadt KH, Powles MA, Fujioka H, Aikawa M, Schmatz DM. Use of 13(1,3)-glucan-specific antibody to study cyst wall of Pneumocystis carinii and effects of pneumocandin B analog L-733,560. Anti microb Agents Chemother 1994; 38: 2258–2265.
  • Vartivarian SE. Virulence properties and nonimmune pathoge-netic mechanisms of fungi. Clin Infect Dis 1992; 14: 530–S36.
  • Travis WD. Pathological Features. In: Walzer PD, ed. Pneumo-cystis carinii Pneumonia 2nd edn. New York: Marcel Dekker, 1994: 155–180.
  • Limper AH, Thomas CF, Anders RA, Leof EB. Interactions of parasite and host epithelial cell cycle regulation during Pneumocystis carinii pneumonia. J Lab Clinical Med 1997; 130: 132–138.
  • Marshall BC, Brown BR, Rothstein MA, Rao NV, Hoidal JR, Rodgers GM. Alveolar epithelial cells express both plasminogen activator and tissue factor. Chest 1991; 99: 25S–27S.
  • Olman MA, Mackman N, Gladson CL, Moser KM, Loskutoff DJ. Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J Clin Invest 1995; 96: 1621–1630.
  • Machovich R, Owen WG. Denatured protein as cofactors for plasminogen activation. Arch Biochem Biophys 1997; 344:343–349.
  • Redlitz A, Fowler BJ, Plow EF, Miles LA. The role of an enolase-related molecule in plasminogen binding to cells. Eur J Biochem 1995; 227: 407–415.
  • Andrionicos NM, Ranson M, Bognacki J, Baker MS. The human EN01 gene product (recombinant human a-enolase) displays characteristics required for a plasminogen binding protein. Biochim Biophys Acta 1997; 1337: 27–39.
  • Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF. Role of cell-surface lysines in plasminogen binding to cells: identification of a-enolase as a candidate plasminogen receptor. Biochemistry 1991; 30: 1682–1691.
  • Nakajima K, Hamanoue M, Takemoto N, Hattori T, Kato K, Kohsaka S. Plasminogen binds specifically to a-enolase on rat neuronal plasma membrane. J Neurochem 1994; 63: 2048–2057.
  • Jackson JC, Lopes JMA cDNA from Schizosaccharomyces pombe encoding a putative enolase. Gene 1995; 154: 109–113.
  • Chen F, Cushion MT. Use of an ATP bioluminescent assay to evaluate viability of Pneumocystis carinii from rats. J Gun Microbiol 1994; 32: 2791–2800.
  • Hong ST, Steele PE, Cushion MT, Walzer PD, Stringer SL, Stringer JR. Pneumocystis carinii karyotypes. J Clin Microbiol 1990; 28: 1785–1795.
  • Merkulova T, Lucas M, Jabet C, et al. Biochemical character-ization of the mouse muscle-specific enolase: developmental changes in electrophoretic variants and selective binding to other proteins. Biochem J 1997; 323:791–800.
  • De Stefano JA, Walzer PD. New biological insight. In: Sattler FR, Walzer PD, eds. Bailliere's Clinical Infectious Diseases. Pneumocystis carinii. London: Baillfere-Tindall; 1995: 409–430.
  • Smulian AG, Stringer JR, Linke MJ, Walzer PD. Isolation and characterization of a recombinant antigen of Pneumocystis carinii. Infect Immun 1992; 60: 907–915.
  • Ashley C, Morhart M, Rennie R, Ziola B. Release of Candida albi cans yeast antigens upon interaction with human neutrophils in vitro. J Med Microbiol 1997; 46: 747–755.
  • Quax PHA, De Bart ACW, Schalken JA, Verheijen JH. Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: correlation with metastatic behavior in vivo. Prostate 1997; 32: 196–204.
  • Angelici E, Contini C, Romani R, Epifano O, Serra P, Canipari R. Production of plasminogen activator and plasminogen activator inhibitors by alveolar macrophages in control subjects and AIDS patients. AIDS 1996; 10: 283–290.
  • De Benedetti E, Nicod L, Reber G, Vifian C, de Moerloose P. Procoagulant and fibrinolytic activities in bronchoalveolar fluid of HIV-positive and HIV-negative patients. Eur Respir J 1992; 5: 411–417.
  • Guadiz G, Sporn LA, Goss RA, Lawrence SO, Marder VJ, Simpson-Haidaris PJ. Polarized secretion of fibrinogen by lung epithelial cells. Am J Respir Cell Mol Biol 1997; 17: 60–69.
  • Simpson-Haidaris PJ, Guadiz G. Host response to inflammation elicited during Pneumocystis carinii pneumonia. J Euk Micro-biol 1997; 44: 33S.
  • Lottenberg R. A novel approach to explore the role of plasminogen in bacterial pathogenesis. Trends Microbiol 1997; 5: 466–468.
  • Leigh JA, Lincoln RA. Streptococcus uberis acquires plasmin activity following growth in the presence of bovine plasminogen through the action of its specific plasminogen activator. FEMS Microbiol 1997; 154: 123–129.
  • Pancholi V, Fischetti VA. a-enolase, a novel strong plasmin(o-gen) binding protein on the surface of pathogenic Streptococci.J Biol Chem 1998; 273: 14503–14515.
  • Coleman JL, Gebbia JA, Piesman J, Degen JL, Bugge TH, Benach JL. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 1997; 89: 1111–1119.
  • Lahteenmaki K, Virkola R, Pouttu R, Kuusela P, Kukkonen M, Korhonen TK. Bacterial plasminogen receptors: in vitro evidence for a role in degradation of the mammalian extra-cellular matrix. Infect Immun 1995; 63: 3659–3664.
  • McCoy HE, Broder CC, Lottenberg R. Streptokinases produced by pathogenic group C streptococci demonstrate species-specific plasminogen activation. J Infect Dis 1991; 164:515–521.
  • Lottenberg R, Minning-Wenz, D, Boyle MDP. Capturing host plasmin(ogen): a common mechanism for invasive pathogens? Trends Microbiol 1994; 2: 20–24.
  • Gozalbo D, Gil-Navarro I, Azorin I, Renau-Piqueras J, Martinez JP, Gil ML. The cell wall-associated glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is also a fibronectin and laminin binding protein. Infect Immun 1998; 66: 2052–2059.
  • Boyle MDP, Lottenberg R. Plasminogen activation by invasive human pathogens. Thromb Haemost 1997; 77: 1–10.
  • Lahteenmaki K, Virkola R, Saren A, Emody L, Korhonen TK. Expression of plasminogen activator Pla of Yersinia pestis enhances bacterial attachment to the mammalian extracellular matrix. Infect Immun 1998; 66: 5755–5762.
  • Bergman A, Linder C, Sakaguchi, K, et al. Increased expression of a-enolase in c-jun transformed rat fibroblasts without increased activation of plasminogen. FEBS Lett 1997; 417: 17–20.
  • Ferreira P, Bras A, Tavares D, et al. Purification, and biochemical and biological characterization of an immunosup-pressive and lymphocyte mitogenic protein secreted by Strepto-coccus sobrinus. Int Immunol 1997; 9: 1735–1743.
  • Watanabe S, Quan CP, Smith LR, Kuroi K, Bouvet JP. Homology of partial primary sequences between a-enolase and a suppresive lymphokine from human T cells. Immun Invest 1996; 25: 397–404.
  • Beck JM, Preston AM, Gyetko MR. Urokinase-type plasmino-gen activator in inflammatory cell recruitment and host defense against Pneumocystis carinii in mice. Infect Immun 1999; 67: 879–884.
  • Alloush HM, Lopez-Ribot JL, Masten BJ, Chaffin WL. 3-Phosphoglycerate kinase: a glycolytic enzyme protein present in the cell wall of Candida albi cans. Microbiology 1997; 143: 321–330.
  • Gil-Navarro I, Gil ML, Casanova M, O'Conner JE, Martinez JP, Gozalbo D. The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is a surface antigen. J Bacteriol 1997; 179: 4992–4999.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.